Apoptosis in asymptomatic HIV-1 seropositives immunized with HIV-1 env glycoprotein (gp160): Effects of administration of Zidovudine in vivo and interleukin-2 in vitro

By Pierdominici M.   Mollicone B.   Ricci G.   Oliva A.   D'Offizi G.   Giovannetti A.   Aiuti F.   Pandolfi F.  

Vaccine, Vol. 16, Iss. 7, 1998-04 ,pp. : 715-721

Elsevier

Access to resources Recommend Favorite

Immunization of mice with recombinant gp41 in a systemic prime/mucosal boost protocol induces HIV-1-specific serum IgG and secretory IgA antibodies

By Mantis N.J.   Kozlowski  

Vaccine, Vol. 19, Iss. 28, 2001-07 ,pp. : 3990-4001

Elsevier

Access to resources Recommend Favorite

A novel epitope R7V common to all HIV-1 isolates is recognized by neutralizing IgG found in HIV-infected patients and immunized rabbits

By Galea P.   Le Contel C.   Chermann J.C.  

Vaccine, Vol. 17, Iss. 11, 1999-03 ,pp. : 1454-1461

Elsevier

Access to resources Recommend Favorite

Linkage of a fusion peptide to a CTL epitope from the nucleoprotein of measles virus enables incorporation into ISCOMs and induction of CTL responses following intranasal immunization

By Hsu S.-C.   Schadeck E.B.   Delmas A.   Shaw M.   Steward M.W.  

Vaccine, Vol. 14, Iss. 12, 1996-08 ,pp. : 1159-1166

Elsevier

Access to resources Recommend Favorite

HIV-1 recombinant gp160 vaccine induced antibodies in serum and saliva

By NIAID AIDS   Gorse G.J.   Rogers J.H.   Perry J.E.   Newman F.K.   Frey S.E.   Patel G.B.   Belshe R.B.  

Vaccine, Vol. 13, Iss. 2, 1995-02 ,pp. : 209-214

Elsevier

Access to resources Recommend Favorite